Xencor Q4 2022 net loss $12M vs net income $73.1M; revenue $21.6M down 86% YoY

Xencor Inc

2022-FY EPS reported -$0.93 revenue$164,579,000

Net loss per share $(0.20) vs EPS $1.21 in Q4 2021; full year net loss $55.2M.
Total revenue $21.6M in Q4 2022 vs $154.0M in Q4 2021; full year revenue $164.6M vs $275.1M.
Cash and securities $613.5M as of Dec 31, 2022; expects to end 2023 with $425-475M.
R&D expenses $51.5M in Q4, comparable to prior year; full year R&D $199.6M up from $192.5M.
Initiated Phase 1 for XmAb819 (ENPP3xCD3) and XmAb808 (B7-H3xCD28); IND for XmAb541 planned.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Xencor Inc reported the fiscal year ended December 31, 2022 results: revenue $164.6 million.

Period: the fiscal year ended December 31, 2022
Revenue: $164.6 million
Result: reported results

Exact text from the filing

Revenues for the full year 2022 were $164.6 million compared to $275.1 million for the same period in 2021.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Xencor Inc reported the fourth quarter ended December 31, 2022 results: revenue $21.6 million.

Period: the fourth quarter ended December 31, 2022
Revenue: $21.6 million
Result: reported results

Exact text from the filing

Total revenue for the fourth quarter ended December 31, 2022 was $21.6 million compared to $154.0 million for the same period in 2021.

View on SEC.gov

Browse all earnings releases →

Xencor Inc filing history →

Source: SEC EDGAR

accession 0001628280-23-004846

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.